Drug repurposing intelligence

Perspica Labs

We find overlooked therapeutic opportunities before they become obvious.

Perspica Labs is a research company focused on drug repurposing opportunities that have not yet been organized into obvious market language.

biology ownership validation cost market timing

What we build

Systems for seeing quiet therapeutic leverage.

We build computational systems for drug repurposing, lifecycle extension, and evidence-driven opportunity discovery.

Our internal work connects public biomedical data, patent-aware reasoning, and low-cost validation pathways into a disciplined opportunity discovery process.

What We Do

A compact research practice around overlooked value.

01

Drug Repurposing Intelligence

We identify hidden links between existing drugs and new therapeutic indications.

02

Lifecycle Extension Strategy

We analyze extension potential that originators or markets have not yet fully recognized.

03

Patent-Aware Opportunity Mapping

We map prior art, claim scope, experimental feasibility, and licensing-out potential together.

04

Low-Cost Validation Design

We design cell-based, mechanism-focused, and biomarker-informed validation strategies before large clinical commitments.

Internal platform

Prometheon is our discovery engine.

Prometheon is Perspica Labs' internal engine for drug repurposing discovery.

It is designed to surface non-obvious therapeutic hypotheses from fragmented biomedical, regulatory, and patent signals.

We do not simply search for what is already known. We look for the spaces where biology, ownership, validation cost, and market timing quietly align.

public biomedical data plausibility
patent-aware reasoning defensibility
low-cost validation pathways execution
commercial timing opportunity

Opportunity criteria

Scientifically plausible. Commercially meaningful. Strategically defensible.

01

Evidence strong enough to deserve a next experiment.

02

Validation path small enough to test before heavy capital is committed.

03

Rights structure clear enough to support a serious licensing conversation.

Confidential partnership inquiries

For confidential partnership inquiries:

Confidential inquiries are welcome.

contact@perspicalabs.com